125 related articles for article (PubMed ID: 31233836)
1. PDS5B regulates cell proliferation and motility via upregulation of Ptch2 in pancreatic cancer cells.
Ma J; Cui Y; Cao T; Xu H; Shi Y; Xia J; Tao Y; Wang ZP
Cancer Lett; 2019 Sep; 460():65-74. PubMed ID: 31233836
[TBL] [Abstract][Full Text] [Related]
2. miR-223 Regulates Cell Proliferation and Invasion via Targeting PDS5B in Pancreatic Cancer Cells.
Ma J; Cao T; Cui Y; Zhang F; Shi Y; Xia J; Wang ZP
Mol Ther Nucleic Acids; 2019 Mar; 14():583-592. PubMed ID: 30776580
[TBL] [Abstract][Full Text] [Related]
3. PDS5B inhibits cell proliferation, migration, and invasion via upregulation of LATS1 in lung cancer cells.
Xu H; Zhou W; Zhang F; Wu L; Li J; Ma T; Cao T; Lian C; Xia J; Wang P; Ma J; Li Y
Cell Death Discov; 2021 Jun; 7(1):168. PubMed ID: 34226509
[TBL] [Abstract][Full Text] [Related]
4. Patched-2 functions to limit Patched-1 deficient skin cancer growth.
Veenstra VL; Dingjan I; Waasdorp C; Damhofer H; van der Wal AC; van Laarhoven HW; Medema JP; Bijlsma MF
Cell Oncol (Dordr); 2018 Aug; 41(4):427-437. PubMed ID: 29869097
[TBL] [Abstract][Full Text] [Related]
5. Reduced PTCH2 expression is associated with glioma development through its regulation of the PTEN/AKT signaling pathway.
Han J; Deng H; Xiong Y; Xia X; Bao C; Chen L; Zhao Q; Zhong S; Peng L; Zhong C
Biochem Biophys Res Commun; 2022 Oct; 627():76-83. PubMed ID: 36027694
[TBL] [Abstract][Full Text] [Related]
6. Hypoxia but not normoxia promotes Smoothened transcription through upregulation of RBPJ and Mastermind-like 3 in pancreatic cancer.
Onishi H; Yamasaki A; Kawamoto M; Imaizumi A; Katano M
Cancer Lett; 2016 Feb; 371(2):143-50. PubMed ID: 26655998
[TBL] [Abstract][Full Text] [Related]
7. NELFE promoted pancreatic cancer metastasis and the epithelial‑to‑mesenchymal transition by decreasing the stabilization of NDRG2 mRNA.
Han L; Zan Y; Huang C; Zhang S
Int J Oncol; 2019 Dec; 55(6):1313-1323. PubMed ID: 31638184
[TBL] [Abstract][Full Text] [Related]
8. MicroRNA-494 acts as a tumor suppressor in pancreatic cancer, inhibiting epithelial-mesenchymal transition, migration and invasion by binding to SDC1.
Yang Y; Tao X; Li CB; Wang CM
Int J Oncol; 2018 Sep; 53(3):1204-1214. PubMed ID: 29956739
[TBL] [Abstract][Full Text] [Related]
9. Knockdown of AGR2 induces cell apoptosis and reduces chemotherapy resistance of pancreatic cancer cells with the involvement of ERK/AKT axis.
Liu QG; Li YJ; Yao L
Pancreatology; 2018 Sep; 18(6):678-688. PubMed ID: 30055941
[TBL] [Abstract][Full Text] [Related]
10. Linc00462 promotes pancreatic cancer invasiveness through the miR-665/TGFBR1-TGFBR2/SMAD2/3 pathway.
Zhou B; Guo W; Sun C; Zhang B; Zheng F
Cell Death Dis; 2018 Jun; 9(6):706. PubMed ID: 29899418
[TBL] [Abstract][Full Text] [Related]
11. Expression of KLF9 in pancreatic cancer and its effects on the invasion, migration, apoptosis, cell cycle distribution, and proliferation of pancreatic cancer cell lines.
Zhong Z; Zhou F; Wang D; Wu M; Zhou W; Zou Y; Li J; Wu L; Yin X
Oncol Rep; 2018 Dec; 40(6):3852-3860. PubMed ID: 30542730
[TBL] [Abstract][Full Text] [Related]
12. PEG10 overexpression induced by E2F-1 promotes cell proliferation, migration, and invasion in pancreatic cancer.
Peng YP; Zhu Y; Yin LD; Zhang JJ; Wei JS; Liu X; Liu XC; Gao WT; Jiang KR; Miao Y
J Exp Clin Cancer Res; 2017 Feb; 36(1):30. PubMed ID: 28193232
[TBL] [Abstract][Full Text] [Related]
13. Sonic Hedgehog-GLI Family Zinc Finger 1 Signaling Pathway Promotes the Growth and Migration of Pancreatic Cancer Cells by Regulating the Transcription of Eukaryotic Translation Initiation Factor 5A2.
Xu X; Liu H; Zhang H; Dai W; Guo C; Xie C; Wei S; He S; Xu X
Pancreas; 2015 Nov; 44(8):1252-8. PubMed ID: 26465952
[TBL] [Abstract][Full Text] [Related]
14. [PDS5B inhibits the proliferation of A549 human lung cancer cells via downregulation of Wnt5a].
Ma L; Ma T; Zhou W; Li J; Li Y; Xu H
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2023 Jan; 39(1):15-20. PubMed ID: 36631010
[TBL] [Abstract][Full Text] [Related]
15. SATB1 Promotes Pancreatic Cancer Growth and Invasion Depending on MYC Activation.
Chen Z; Li Z; Li W; Zong Y; Zhu Y; Miao Y; Xu Z
Dig Dis Sci; 2015 Nov; 60(11):3304-17. PubMed ID: 26108419
[TBL] [Abstract][Full Text] [Related]
16. ANLN-induced EZH2 upregulation promotes pancreatic cancer progression by mediating miR-218-5p/LASP1 signaling axis.
Wang A; Dai H; Gong Y; Zhang C; Shu J; Luo Y; Jiang Y; Liu W; Bie P
J Exp Clin Cancer Res; 2019 Aug; 38(1):347. PubMed ID: 31395079
[TBL] [Abstract][Full Text] [Related]
17. Inhibiting YAP expression suppresses pancreatic cancer progression by disrupting tumor-stromal interactions.
Jiang Z; Zhou C; Cheng L; Yan B; Chen K; Chen X; Zong L; Lei J; Duan W; Xu Q; Li X; Wang Z; Ma Q; Ma J
J Exp Clin Cancer Res; 2018 Mar; 37(1):69. PubMed ID: 29587800
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of DACH1 activity by short hairpin RNA represses cell proliferation and tumor invasion in pancreatic cancer.
Bu XN; Qiu C; Wang C; Jiang Z
Oncol Rep; 2016 Aug; 36(2):745-54. PubMed ID: 27278537
[TBL] [Abstract][Full Text] [Related]
19. TSPAN1 upregulates MMP2 to promote pancreatic cancer cell migration and invasion via PLCγ.
Zhang X; Shi G; Gao F; Liu P; Wang H; Tan X
Oncol Rep; 2019 Apr; 41(4):2117-2125. PubMed ID: 30720116
[TBL] [Abstract][Full Text] [Related]
20. LincRNA-ROR promotes invasion, metastasis and tumor growth in pancreatic cancer through activating ZEB1 pathway.
Zhan HX; Wang Y; Li C; Xu JW; Zhou B; Zhu JK; Han HF; Wang L; Wang YS; Hu SY
Cancer Lett; 2016 May; 374(2):261-71. PubMed ID: 26898939
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
